Metastases free thyroid cancer patients harbouring TERT mutations may benefit from a more intensive treatment and follow-up
- PMID: 31328110
- PMCID: PMC6606473
- DOI: 10.21037/gs.2019.05.05
Metastases free thyroid cancer patients harbouring TERT mutations may benefit from a more intensive treatment and follow-up
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma.Eur J Cancer. 2019 Feb;108:41-49. doi: 10.1016/j.ejca.2018.12.003. Epub 2019 Jan 12. Eur J Cancer. 2019. PMID: 30648628
References
Publication types
LinkOut - more resources
Full Text Sources